Results 21 to 30 of about 384,078 (314)

Interference of lupus anticoagulant causing antiprothrombin and anti–beta-2-glycoprotein I antibodies on international normalized ratio measurements: comparative analysis of international normalized ratio methods [PDF]

open access: yesResearch and Practice in Thrombosis and Haemostasis
Background: Life-long vitamin K antagonist (VKA) therapy is recommended as a standard of care in antiphospholipid syndrome (APS) patients with thrombosis.
Rachel Gehlen   +7 more
doaj   +2 more sources

Studies on specific interaction of beta-2-glycoprotein I with HBsAg

open access: hybridWorld Journal of Gastroenterology, 2003
To observe the binding activity of beta-2-glycoprotein I(beta(2)GPI) to hepatitis B surface antigen (HBsAg) and the possible roles of beta(2)GPI in hepatitis B virus (HBV) infection.The rationale of ELISA methods and ELISA-based research method and ligand-blotting technique were used to detect the specific interaction of beta(2)GPI with HBsAg.With the ...
Pujun Gao
openalex   +4 more sources

Renal Transplantation Dramatically Reduces IgA Anti-beta-2-glycoprotein I Antibodies in Patients with Endstage Renal Disease [PDF]

open access: yesJournal of Immunology Research, 2014
IgA anti-beta-2-glycoprotein I (aB2GPI) antibodies have been related to vascular pathology in the general population and mainly in hemodialyzed patients (prevalence 33%) in whom an elevated incidence of thrombosis and mortality is found. In this paper we
Manuel Serrano   +9 more
doaj   +2 more sources

Beta-2 Glycoprotein I IgA Isotype: An Important Consideration in Secondary Hypertension. [PDF]

open access: yesCureus
Anti-beta-2 glycoprotein I antibodies are an important player in hypercoagulable states, including those that lead to antiphospholipid syndrome. Traditionally, assays have only detected IgG and IgM isotypes of this antibody. However, newer assays also detect the IgA isotype. The problem lies in the largely unknown significance of this IgA isotype. This
Fusillo TF, Capicotto L, Gill J.
europepmc   +3 more sources

Interaction of the antiphospholipid syndrome autoantigen beta-2 glycoprotein I with DNA and neutrophil extracellular traps. [PDF]

open access: yesClin Immunol, 2023
Kmeťová K   +13 more
europepmc   +2 more sources

Cardiolipin interacts with beta-2-glycoprotein I and forms an open conformation-Mechanisms analyzed using hydrogen/deuterium exchange. [PDF]

open access: yesProtein Sci, 2021
Beta‐2‐glycoprotein I (β2GPI) is the major antigen for the antiphospholipid antibodies in the antiphospholipid syndrome. The exposed epitope in domain I of β2GPI can be recognized by the anti‐β2GPI antibody.
Tang KT, Wu TY, Chen HH, Lin CC, Hsu YH.
europepmc   +2 more sources

Anticardiolipin and anti-beta-2 glycoprotein I antibodies in patients with moderate or severe COVID-19. [PDF]

open access: yesAm J Med Sci, 2023
Garcia-Arellano G   +7 more
europepmc   +2 more sources

Complete amino acid sequence of human plasma beta 2-glycoprotein I. [PDF]

open access: greenProceedings of the National Academy of Sciences of the United States of America, 1984
We have determined the complete amino acid sequence of beta 2-glycoprotein I (Mr, congruent to 50,000), a human plasma protein that is associated with lipids and binds to platelets but whose function is not yet known.
Jay N. Lozier   +2 more
openalex   +2 more sources

The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS.

open access: yesBlood Rev, 2020
McDonnell T   +8 more
europepmc   +2 more sources

In vivo evidence of angiogenesis inhibition by β2-glycoprotein I subfractions in the chorioallantoic membrane of chicken embryos [PDF]

open access: yesBrazilian Journal of Medical and Biological Research, 2021
The vascular network expansion and functioning are important factors affecting normal intra-uterine fetal development. This study addressed the previously reported antiangiogenic potential of beta-2-glycoprotein I (β2GPI) in vivo in the chick embryo ...
C.M. Baldavira   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy